Establishing associations between environmental agents and disease presents challenges to both epidemiologists and toxicologists, particularly in cases of complex geneenvironment interactions and when there is a long latency between exposure and disease. Biologic markers, physiological signals that reflect exposure, early cellular response, or inherent or acquired susceptibilities,provide a new strategy for resoMng some of these problems. Biomarker research assumes that toxicant-induced diseases are progressive and that injury proceeds from entry of the toxicant into target cells, which induces subcellular biochemical events, to cell-and organ-level events that eventually induce irreversible or persistent organism dysfunction.The epidemiologic value of a biomarker lies in its ability to predict backward toward exposure and forward toward risk of clinical outcome, which is largely unknown. Research in mechanistic toxicology will advance the range of useful biomarkers in epidemiology and clinical medicine.
Indexing Terms: biomarker validation/environmental hazards
Chronic diseases such as cancer, heart disease, neurological disorders, and respiratory afflictions have, with the exception of the acquired immunodeficiency syndrome, replaced infectious diseases as the principal causes of deaths and illness in developed countries today. Because patterns and rates of these chronic diseases vary between and within countries, it is believed that a significant portion are related to environmental factors and, as such, may be preventable.
Genetics, host factors, and environmental factors, broadly conceived, are major doterminants of health. Environmentally induced disease may be generally defined to include all conditions that are acquired and are not solely the consequence of heritable genetic mutations.
These categories maybe difficult to distinguish in all cases because environmental exposures, such as radiation, can cause mutations in the germ cell that may be transmitted to offspring and because "not all that is familial is inherited"
(1). 
Biomarkers: Concepts and Definitions
Over the past decade, the concept of biomarkers has been developed to assess the relation between environmental exposures and subsequent disease in individuals and groups (7) . Better characterization of exposure increases the sensitivity of studies on environmental health outcomes. Thus, the practical goal of biomarker research and application is to prevent disease by reducing exposures to hazardous agents through the early identification of exposure and response. This strategy assumes that toxicity progresses from early subcellular events to severe disease, and that each step in the progression increases the likelihood of the next step. Biomarkers, defined as signaling events in biological systems, can sometimes be identified at the molecular or subcellular level (8). Biomarkers can be conceptualized, as shown in Fig. 1 (8) , and defined in three operational classes: exposure, effect (or response), and susceptibility. Here we review some problems in the validation of biomarkers of exposure in the study of environmental health, discuss some limits of the developing field, and identify some important research opportunities in this growing area.
Within the three broad classes of markers, there is considerable flexibility of definition. The same signal can be used as a marker of exposure, effect, or susceptibility, depending on the purpose and design of an epidemiological or toxicological study. For example, the enzyme S-aininolevulinic acid dehydrase (ALAD) has been widely used as a biomarker of exposure to lead (9, 10). ALA]) inhibition is also an effect or response to lead on heme biosynthesis, and its significance depends on its role in the mechanism of cell or organ toxicity [e.g., cellular anoxia, anemia, altered hepatic drug metabo-
lism, or central nervous system (CNS) toxicity] (11, 12).
ALAD may also be a marker of susceptibility, because it is heterozygously expressed in human populations and differing alleles for the ALA]) gene may confer differing sensitivity to lead (13, 14). 
Umits
Biomarkers are limited by the following constraints, some of which are amenable to change through research: lack of knowledge of the target organ system and mechanisms of toxic response, lack of access to relevant biological events, lack of knowledge of toxicokinetics, lack of sufficient sensitivity and specificity, and inherent or interindividual variability in the signal. These latter constraints lead to difficulties in determining baseline or normal levels of exposure. Only as we understand the toxicokinetics and mechanisms of action of specific toxicants will we be able to identify new biomarkers that truly assist us in the prevention of environmental disease. Experimental research will thus remain an important component of public health research, because it permits the assessment of biomarkers in controlled experimental systems that can sometimes be validated in human studies. New techniques will facilitate the measurement of molecular biomarkers in tissue so that we can better determine the relations between markers of exposure and the health effects with which they are ultimately linked.
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